Hadley Harbor Master Investors (Cayman) L.P. is > 10% Shareholder of CRISPR Therapeutics AG. Currently has a direct ownership of 744,380 shares of CRSP, which is worth approximately $40.6 Million. The most recent transaction as insider was on Oct 24, 2016, when has been sold 744,380 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 744K
0% 3M change
0% 12M change
Total Value Held $40.6 Million

Hadley Harbor Master Investors (Cayman) L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 24 2016
BUY
Conversion of derivative security
-
744,380 Added 50.0%
744,380 Common Shares
HHM

Hadley Harbor Master Investors (Cayman) L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP